logo

Practice Recommendation 1 Pneumococcal vaccines as a preventive measure for dealing with pneumonia in older adults

   

Added on  2021-04-17

6 Pages931 Words484 Views
Running head: PRACTICE RECOMMENDATIONSPRACTICE RECOMMENDATIONSName of the StudentName of the universityAuthor’s note

1PRACTICE RECOMMENDATIONSDescription of the practice recommendation 1Pneumococcal vaccines can be considered as a preventive measure for dealing with pneumonia in older adults. According to Assaad et al., (2012) vaccination is a primary preventive strategy for the elders suffering against Streptococcus pneumonia and other influenza infections. The efficiency of the pneumococcal vaccine has not been established firmly due to the lack of the randomized control trials involving the patients greater than 65 years of age. According to Assad et al., (2012) vaccination is a primary preventive strategy for the elders suffering against Streptococcus pneumonia and other influenza infections. The efficiency of the pneumococcal vaccine has not been established firmly due to the lack of the randomized control trials involving the patients greater than 65 years of age. Studies have shown that PCV7 has beenhighly effective in preventing the invasive pneumococcal disease in the older adults. In 2010, FDA has given license to PCV 13, which can provide protection against infections caused by 6 more serotypes than the PCV7. CDC has recommended pneumococcal vaccines for all the adultswho are 65 years older or more. Strength of recommendation with integration of GRADE criteriaType of evidence- Review

2PRACTICE RECOMMENDATIONSIncreased grade- As it bears a strong evidence of association with a relative risk of >5(<0.2) based on evidence. The strength of this study is that it provides a wide view of the outcomes of the acute disease with which the physicians have to deal with. The paper gives information regarding the recent recommendations of the advisory committee on the Immunization practice for people above 65 years age. It can also be known about the various antibody responses occurring following the vaccination. The paper also reveals the fact that effectiveness of the PPSV23 in mitigating the symptoms of pneumonia is controversial. Several studies have showed that PPSV23 have brought about the reduction of the deaths among the older adults.The strength of this study is that it provides the rationale for taking up pneumococcal vaccine by the older adults. Recommendation 2The peer reviewed literature will help to provide information regarding the effect of the influenza virus, the mode of action of the vaccine, the portals of entry of the virus and different evidences supporting the effectiveness of the influenza vaccine. Seasonal or pandemic influenza are often complicated by the bacterial infection. Influenza A virus is one of the most common pathogen that is responsible for causing respiratory illness in older adults. According to Lang ET AL.,(2012), According to the author the influenza vaccine are effective and can act as cost effective for the elderly population. The paper describes about a randomized control trial that hasbeen done involving a group of healthy volunteers over the age of 60 and they were randomly assigned for getting a placebo or an influenza vaccine that is trivalent inactivated.

End of preview

Want to access all the pages? Upload your documents or become a member.

Related Documents
Effect of Influenza Vaccine on Contracting Pneumonia in Older Adults
|15
|1008
|378

Evaluation of Annual Influenza Vaccination for Older Adults and Community Nurses
|10
|2934
|151

Management of Respiratory Tract Infections in Children
|4
|696
|53

Interventions to Increase Influenza Vaccination Rates of those 60 years and Older Living in the Community
|4
|904
|114

Pulmonary Rehabilitation Programs to Patients Suffering from COPD
|15
|4688
|236

Health Law and Ethics Assignment 2022
|14
|4034
|17